Antifungal Activities of Different Extracts of Marine Macroalgae Against Dermatophytes and Candida Species
- 862 Downloads
Algae are bioactive natural resources, and due to the medical importance of superficial mycoses, we focused the action of macroalgae extracts against dermatophytes and Candida species. Seaweed obtained from the Riacho Doce beach, Alagoas (Brazil), were screened for the antifungal activity, through crude extracts using dichloromethane, chloroform, methanol, ethanol, water and chloroform and hexane fractions of green, brown and red algae in assays with standard strains of the dermatophytes Trichophyton rubrum, T. tonsurans, T. mentagrophytes, Microsporum canis, M. gypseum and yeasts Candida albicans, C. krusei, C. guilliermondi and C. parapsilosis. The M44-A and M27-A2/M38A manuals by CLSI were followed, and the minimum inhibitory concentration (MIC) ranged from 0.03 to 16.00 μg ml−1, and an inhibition halo of 10.00–25.00 mm was observed for dermatophytes, while for yeast, it was from 8.00 to 16.00 μg ml−1 and 10.00–15.00 mm. M. canis showed MIC of 0.03 μg ml−1 and the largest inhibition halo in T. rubrum (25.00 mm) through the use of the methanol extract. For C. albicans, dichloromethane, methanol and ethanol extracts formed the largest inhibition halo. The ethanol extract was shown to be the best inhibiting fungi growth, and chloroform and hexane fractions of H. musciformis inhibited the growth of all dermatophytes and C. albicans, yielding the conclusion that apolar extracts obtained from algae presented the best activity against important pathogenic fungi.
KeywordsDermatophyte Trichophyton Candida Macroalgae Extracts
We are grateful to Ana Maria Queijeiro Lopes (IQB/UFAL) and Eurípedes Alves Silva Filho (ICBS/UFAL) for suggestions, Júlio César Voltolini for support in statistical analysis and to Abilio Borghi for the English review on the manuscript. This work was supported by grants from the CAPES.
Conflict of interest
There is no conflict of interest in this paper, and all authors agree to publication.
- 6.Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011;3:5771.Google Scholar
- 7.Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Soberl JD. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of american. Clin Infect Dis. 2009;48:503–35.PubMedCrossRefGoogle Scholar
- 9.Tresoldi T, Barison EM, Pereira RM, Padoveze MC, Trabasso P. Risk factors associated witch the acquisition of multiresistant bacteria in pediatric nursery. J Pediatr. 2000;4:275–86.Google Scholar
- 14.Del Val GA, Platas G, Basilio A. Screening of antimicrobial activities in red, green and brown macoalgae from Gran Canaria (Gran Canary Islands, Spain). Int Microbiol. 2001; 4: 35–40.Google Scholar
- 15.Alves PM, Leite PAAS, Pereira JV, Pereira LF, Pereira MSV, Higino JS, Lima EO. Antifungal activity of the extract of Psidium guajava Linn. (“goiabeira”) upon leavens of Candida of the oral cavity: an in vitro evaluation. Braz J Pharm. 2006; 16: 192–6Google Scholar
- 20.Clinical and Laboratory Standard Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A, Wayne, PA. 2002.Google Scholar
- 21.Fernandez-Torres B, Cabanes FJ, Carrillo-Munoz AJ, Inza I, Guarro J. Collaborative evaluation of optimal antifungal susceptibility testing condition for dermatophytes. J Clin Microbiol. 2002; 40: 3999–4003.Google Scholar
- 22.Barros MES, Santos DA, Hamdan JS. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J Clin Microbiol. 2007; 56: 514–18.Google Scholar
- 23.Clinical and Laboratory Standard Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeast fungi. Approved Standard Document M27-A, Wayne PA. 2008.Google Scholar
- 24.Chiheb I, Riadi H, Martinez-Lopez J, Dominguez SJF, Gomez VJA, Bouziane H, Kadiri M. Screening of antibacterial activity in marine green and brown macroalgae from the coast of Morocco. Afr J Biotechnol. 2009;8:1258–62.Google Scholar
- 26.Ballesteros E, Martin D, Uriz MJ. Biological activity of extracts from some Mediterranean macrophytes. Bot Mar 1982; 35: 481–5.Google Scholar
- 29.Bhakuni DS, Rawat DS. Bioactive marine natural products. USA: Anamaya Publishers and Springer; 2005. p. 346.Google Scholar
- 30.Melo VMM, Medeiros DA, Rios FJB, Castelar LIM, Carvalho AFFU. Antifungal properties of proteins (agglutinins) from the red algae Hypnea musciformis (Wulfen) Lamouroux. Bot Mar 1997; 40: 281–84Google Scholar
- 31.Cordeiro RA, Gomes VM, Carvalho AFFUM, Maciel VM. Effect of Proteins from the Red Seaweed Hypnea musciformis(Wulfen) Lamouroux on the Growth of Human Pathogen Yeasts. Braz Arch Biol Technol 2005; 49: 915–21.Google Scholar
- 32.Tuney BH, Cadirci D, Ünal A, Sukatar A. Antimicrobial activities of the extracts of marine algae from the coast of Urla (Izmir, Turkey). Turk J Biol. 2006;20:171–5.Google Scholar
- 34.Orandy MA, Verde MJ, Martinez-Lozano SJ, Waksman NH. Active fractions from species of marine algae. Intern J Exp Bot 2004; 165–70.Google Scholar